Aris Global, LLC Wins Prestigious Frost & Sullivan Pharmacovigilance Customer Value Enhancement Award
6/24/2013 10:11:35 AM
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
STAMFORD, CT—June 24, 2013— ArisGlobal, a leading provider of solutions to the life science industry, has won the Frost & Sullivan North American Pharmacovigilance Software Customer Value Enhancement Award in recognition of accomplishments, innovation and customer focus in the Pharmacovigilance sector.
The award is presented each year to the company that has demonstrated excellence in implementing strategies that proactively create value for its customers with a focus on improving the return on investment (ROI) that customers make in its services or products.
Frost & Sullivan is in its 50th year in business with a global research organization of 1,800 analysts and
consultants who monitor more than 300 industries and 250,000 companies. The company’s research philosophy originates form the CEO’s 360 Degree Perspective™, which serves as the foundation of its TEAM Research™ methodology. This unique approach enables them to determine how best-in-class companies worldwide manage growth, innovation and leadership.
Frost & Sullivan noted that ArisGlobal solutions allow safety processing beyond just regulatory diligence, helping comprehensive risk management in a streamlined manner and that the company is innovation driven with software tools developed completely in-house through years of dedicated research and development. The award citation states, “They understand the changing needs of the industry and take an integrated but flexible approach to adverse event and related information collection, triage, management, report preparation and e-submissions management and tracking.”
“We are delighted to have won this prestigious award for our Total Safety solution,” said Deepak Abbhi, President & CEO of ArisGlobal. “Without an integrated solution like our ARISg / ARISj–powered Total Safety suite, companies are forced to use multiple systems, databases, environments, configurations and workflows and duplicate or double enter-cases, which is both risky and inefficient. Because our clients are global, we developed and deliver the world’s only globally accepted safety and pharmacovigilance solution that meets the needs of Europe, North America and Japan.”
The Total SafetyTM modular suite, spearheaded by market-leading ARISg™ and ARISjTM, enables ArisGlobal clients to seamlessly add functionality when and where they need it – and only when they’re ready. As the only approved single, global safety solution in the industry, ArisGlobal is uniquely equipped to enable uniform, efficient operations that fully support all global reporting requirements for EMA (European Medical Agency) and the FDA (US Food & Drug Administration), as well as regulatory reporting requirements for the MHLW/PMDA (Ministry of Health, Labor and Welfare / Pharmaceutical and Medical Device Agency) in Japan, which is one of the three ICH regions.
ArisGlobal is focused on solving business problems for their clients with solutions that are totally integrated. In addition to Total SafetyTM, ArisGlobal offers the market-leading solution for planning and managing global product portfolios and complete regulatory tracking, an integrated eClinical platform that revolutionizes the way sponsors conduct their clinical research programs, and the best in class medical information management system that offers a complete solution to automate and streamline inquiry handling processes.
ArisGlobal (www.arisglobal.com) is the leading provider of integrated software solutions for pharmacovigilance and safety, regulatory affairs, clinical research and quality & compliance for medical inquiries. Life science companies using ArisGlobal’s solutions can better build and maintain the trust they need with their customers, medical practitioners and regulatory bodies around the world.
+ 44 (0)7748905039
Help employers find you! Check out all the jobs and post your resume.